Table 3:
Treatment contrasts on Primary Outcome: PDHD Months 1-12
| Mixed Effects MAR Analysis |
Pattern Mixture NMAR Analysis |
GEE MCAR Analysis |
|||||
|---|---|---|---|---|---|---|---|
| Contrast | Estimate (95% CI) |
P-value | Cohen’s d | Estimate (95% CI) |
P-value | Estimate (CI 95%) |
P-value |
| TAU - TMC | 0.78 (0.13, 1.43) |
0.018 | 0.35 | 0.82 (0.17 1.47) |
0.013 | 0.78 (0.13 1.43) |
0.017 |
| TAU - ACHESS | 0.67 (0.06, 1.28) |
0.031 | 0.31 | 0.69 (0.08 1.30) |
0.027 | 0.67 (0.04 1.30) |
0.038 |
| TAU – TMC+ACH | 0.80 (0.19, 1.41) |
0.009 | 0.36 | 0.83 (0.22 1.44) |
0.007 | 0.80 (0.19 1.41) |
0.009 |
| TMC - ACHESS | −0.11 (−0.76, 0.54) |
0.732 | −0.04 | −0.14 (−0.79 0.51) |
0.676 | −0.11 (−0.72 0.50) |
0.717 |
| TMC – TMC+ACH | 0.02 (−0.63, 0.67) |
0.947 | 0.02 | 0.01 (−0.64 0.66) |
0.977 | 0.02 (−0.55 0.59) |
0.939 |
| ACHESS – TMC+ACH | 0.13 (−0.48, 0.74) |
0.661 | 0.06 | 0.15 (−0.46 0.76) |
0.631 | 0.13 (−0.44 0.70) |
0.645 |
Treatment contrast analyses controlled for recruitment site, gender, any drug use at baseline, and baseline PDHD
PDHD: Percent Days Heavy Drinking